Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant

NCT06928779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: Dazucorilant

Sponsor

Corcept Therapeutics